» Articles » PMID: 16900270

Ocular Surface Sealants and Adhesives

Overview
Journal Ocul Surf
Specialty Ophthalmology
Date 2006 Aug 11
PMID 16900270
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Tissue adhesives, both synthetic and biologic, have a long history of use in ophthalmology. Cyanoacrylate-based glues have traditionally been the most widely used glues for various purposes. They have been specially useful for treating corneal perforations and have had significantly improved long-term outcomes. More recently, fibrin-based glues have gained a major role as a suture substitute for attaching biologic tissues and as surface sealants. The literature supports expanded use of fibrin glue in this fashion. Other new agents, such as polyethyelene glycols, have been underutilized and hold promise, especially as surface protectants. Numerous other glues are being developed and show promise as ocular surface sealants and protective membranes. Advances in knowledge about tissue adhesives are leading to more effective and efficient ophthalmic care.

Citing Articles

Engineering a drug eluting ocular patch for delivery and sustained release of anti-inflammatory therapeutics.

Chen X, Gholizadeh S, Ghovvati M, Wang Z, Jellen M, Mostafavi A AIChE J. 2024; 69(6).

PMID: 38250665 PMC: 10798673. DOI: 10.1002/aic.18067.


Application of Convergent Science and Technology toward Ocular Disease Treatment.

Bal-Ozturk A, Ozcan-Bulbul E, Gultekin H, Cecen B, Demir E, Zarepour A Pharmaceuticals (Basel). 2023; 16(3).

PMID: 36986546 PMC: 10053244. DOI: 10.3390/ph16030445.


Unusual case of dislocation of cyanoacrylate glue into the anterior chamber.

Mukhija R, Trim M, Nanavaty M BMJ Case Rep. 2023; 16(1).

PMID: 36720513 PMC: 9890828. DOI: 10.1136/bcr-2022-254235.


Photocurable GelMA Adhesives for Corneal Perforations.

Barroso I, Man K, Robinson T, Cox S, Ghag A Bioengineering (Basel). 2022; 9(2).

PMID: 35200405 PMC: 8868637. DOI: 10.3390/bioengineering9020053.


Treatment of Non-Infectious Corneal Injury: Review of Diagnostic Agents, Therapeutic Medications, and Future Targets.

Dang D, Riaz K, Karamichos D Drugs. 2022; 82(2):145-167.

PMID: 35025078 PMC: 8843898. DOI: 10.1007/s40265-021-01660-5.